Home › SONACOMS › Filing
🔔 Get instant alerts when SONACOMS files quarterly results on BSE Start free trial →

Press Release

Filed: 26 Oct 2026, 17:27 IST Exchange: NSE Category: Financial Results — Press Release
Press Release - Q2FY27 - Revenue Rs 15.47bn +35% y-y; EBITDA Rs 3.56bn +23% y-y (margin 23.0%); PAT Rs 2.23bn +29% y-y - BEV revenue surged 129% y-y, reaching 51% of automotive revenues in Q2 - Strong order additions of Rs 36bn raised net order book to Rs 251bn, second highest ever - Commercialised 3 new products including helical limited slip differential for EVs - Driveline Division awarded 2026 Deming Prize for Total Quality Management - H1 FY27 revenue Rs 28.57bn +43% y-y; PAT Rs 4.03bn +36% y-y - MD: "Strong growth, new products, order wins and cash generation give confidence in 10X ambition"
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 SONACOMS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add SONACOMS to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Sona BLW Precision Forgings Limited

Important. The summary above is generated automatically from Sona BLW Precision Forgings Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.